We established a quick response research team to monitor the impacts of global pandemic COVID19 on this market to keep our clients informed about latest data and changing strategies. The report will incorporate these insight and data factors. ×
Market Research Report

Global Muscle Relaxant Drugs Industry Analysis: By Drugs Type, By Route Of Administration, By Distribution Channel, By Geography With COVID-19 impact | Forecast Period 2017-2030

Published Date :


Report Pages :


Format :


Region Covered :


Global Muscle Relaxant Drug Market Outlook

Muscle relaxants drugs are related to symptomless rise in serum aminotransferase levels in up to 5% of subjects, but the rate of such eminence may be the same in control, untreated subjects, and significant rises are rare. Growing popularity of anti-aging treatments among the population coupled with trend of number of spa and salons is gaining traction in this market. Factors such as growing geriatric population, approvals of new label indications, growing skin related problems and rising number of surgeries are the major contributors to the growth of the muscle relaxant drugs market worldwide. However, severe side effects related to muscle relaxant drugs such as habituation and respiratory arrest will restrict the growth of global muscle relaxant drugs market. Global muscle relaxant drugs market is anticipated to grow at a significant compound annual growth rate of 6.67% over the forecast period 2017-2030. Low back pain has been ranked among the top 5 causes of physician visits in the U.S. and skeletal muscle relaxants are recommended as a second line therapy for low back pain. Even though muscle relaxants drugs are not recommended as a first line of therapy around 40% of patients suffering from non-specific lower back pain are prescribed with muscle relaxants in the U.S.

Global Muscle Relaxant Drugs Market Segmentation

By Drugs Type

  • Facial Muscle Relaxant Drugs
  • Skeletal muscle Relaxant Drugs
  • Neuromuscular Blocking Agents

The skeletal muscle relaxant drugs dominated the muscle relaxant drugs market and accounted for 57.6% of the overall market share owing to the presence of a large patient pool with musculoskeletal disorders and developing drugs for the treatment of niche indications such as upper limb and lower limb spasticity. However, facial aesthetic relaxants segment is projected to witness highest growth rate i.e. 6.78% owing to increasing number of facial and cosmetic surgeries. Increasing usage of neuromuscular blocking agents during general surgeries would drive the growth of global market for muscle relaxant drugs.

By Route Of Administration

  • Oral
  • Topical
  • Parenteral

By Distribution Channel

  • Online Stores
  • Drug Stores
  • Hospitals
  • Clinics

By Geography

  • North America (US, Canada) {Market Share (%), Market Size (USD Billion)} Muscle Relaxant Market
  • Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion)} Muscle Relaxant Market
  • Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion)} Muscle Relaxant Market
  • Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion)} Muscle Relaxant Market
  • Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion)} Muscle Relaxant Market
  • Rest of the World {Market Share (%), Market Size (USD Billion))} Muscle Relaxant Market

On the basis of region, North America dominated the global muscle relaxant drugs market and accounted for market share of 43.2% in 2017 followed by Europe and APAC being the opportunistic market owing to rising number of ANDA applications being filed by the key players and exponential rise in the cases of multiple sclerosis and fibromyalgia.

Covered In This Muscle Relaxant Drug Market Report

The report covers the present ground scenario and the future growth prospects of the facility management market for 2017-2030 along with the market players’ analysis. We calculated the market size and revenue share on the basis of revenue generated from major players worldwide. Muscle Relaxant Drug market is forecasted on the basis of revenue analysis, product benchmarking and strategic developments of key market players.

Muscle Relaxant Drug Market Outlook 2017-2030, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the Muscle Relaxant Drug market space. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. “Muscle Relaxant Drug Market Report” also recognizes value chain analysis to understand the cost differentiation, pricing models to provide competitive advantage to the existing and new entry players.

COVID-19 imapct on "Global Muscle Relaxant Drugs Market"    

Impact of COVID-19 Outbreak on “Global Muscle Relaxant Drugs Market”, Manufacturers, Contract Manufacturers Suppliers and Recovery Strategy. A complete detailed chapter of 50-70 pages which includes the data and information focused on impacts of the pandemic on the Global Muscle Relaxant Drugs Market. It also showcases the expected recovery schedule and losses in the industry and other various major factors.

Key Market Players

Our Muscle Relaxant Drug Market Report comprises of the following companies as the key players:

  • Pfizer
  • Allergan
  • Ipsen Group
  • Teva Pharmaceuticals
  • Novartis
  • Acorda Therapeutics
  • Aldeyra Therapeutics
  • Canbex Therapeutics
  • Daewoong
  • Emcure Pharmaceuticals
  • Endo International
  • Fresenius Kabi
  • Galderma
  • INSYS Therapeutics
  • Johnson & Johnson
  • Lannett Company
  • Merz Pharma
  • Mylan
  • Par Pharmaceutical
  • PhytoTech Therapeutics
  • Revance Therapeutics
  • Sun Pharmaceutical Industries
  • Takeda Pharmaceutical.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send us the sample request.

Key questions answered in this Muscle Relaxant Drug Market Report

  • What is the total market size by 2030 and what would be the expected growth rate of market?
  • What is the total revenue per segment and region in 2017-18 and what would be the expected revenue per segment and region over the forecast period?
  • What are the key market trends?
  • What are the factors which are driving this market?
  • What are the major barriers to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities for the existing and entry level players?
  • What are the recent developments and business strategy of the key players?

Reasons to buy this market study

  • Facilitate decision-making based on strong historic and forecast data for Muscle Relaxant Drug Market
  • Develop strategies based on the latest regulatory framework
  • Position yourself to gain the maximum advantage of the Healthcare industry’s growth potential
  • Identify key partners and business development avenues across the globe
  • Respond to your competitors’ business structure, strategy and prospects
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the muscle relaxant drug market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies

{ }

Global Muscle Relaxant Drugs Industry Analysis: By Drugs Type, By Route Of Administration, By Distribution Channel, By Geography With COVID-19 impact | Forecast Period 2017-2030

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747

Table of Contents

Please Select Linenece Type